2-(4-Fluorophenyl)-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-amine, 95.0%, 250mg

Methyl Bromo(phenyl)acetate, 97.0%, 25g

Ethyl 3-chloro-2,4-dioxopentanoate, 85.0%, 5g

(4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-phenyloxazole], 97%, 1g

2-(2-Methyl-1H-imidazol-1-yl)ethanamine dihydrochloride, 95.0%, 1g

2-[(4-Nitrophenyl)sulfanyl]acetic acid, 95%, 1g

1,1,3-Trichlorotrifluoroacetone, 97.0%, 5g

6-Methylnaphthalene-1-carboxylic acid, 95+%, 500mg

(R)-3-Methyl-1-phenylbutan-1-amine hydrochloride, 95.0%, 100mg

Pyriproxyfen>98.0%(GC)(T)25g

2-Amino-1-(4-fluoro-phenyl)-ethanone; hydrochloride, 95.0%, 250mg

4-Chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazine, 98%, 500mg

p-Anisidina, >=98%, para síntesis, 250 g, envase de vidrio